Shucheng Gu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.
Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 30, 2016
MRI for assessment of iron overload in patients with hematologic disease
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 14, 2016
Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
Journal: American journal of translational research
Published: April 22, 2015
The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 11, 2015
Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53/p21 pathway in myelodysplastic syndromes.
Journal: European journal of haematology
Published: May 14, 2014
Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis.
Journal: American journal of clinical pathology
Published: November 15, 2013
Impaired osteogenic differentiation of mesenchymal stem cells derived from bone marrow of patients with lower-risk myelodysplastic syndromes.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: October 08, 2013
High expression of APAF-1 elevates erythroid apoptosis in iron overload myelodysplastic syndrome.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 16, 2013
The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.
Journal: Hematology (Amsterdam, Netherlands)
Published: April 02, 2013
Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.
Journal: European journal of haematology
Published: January 13, 2013
Aberration of p73 promoter methylation in de novo myelodysplastic syndrome.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 14, 2012
SDF-1/CXCR4 signal is involved in decreased expression of p57kip2 in de novo MDS patients.
Journal: Hematology (Amsterdam, Netherlands)
Published: August 15, 2012
Last Updated: 09/26/2026